Current and historical daily PE Ratio for Vectus Biosystems Ltd (
ASX:VBS
) from 2016 to Jun 08 2023. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Vectus Biosystems stock (ASX:VBS) PE ratio as of Jun 08 2023 is 0.
More Details
Vectus Biosystems Ltd (ASX:VBS) PE Ratio (TTM) Chart
Vectus Biosystems Ltd (ASX:VBS) PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Total 1273
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Vectus Biosystems PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2023-06-08 | At Loss | 2023-04-07 | At Loss |
| 2023-06-08 | At Loss | 2023-04-06 | At Loss |
| 2023-06-07 | At Loss | 2023-04-05 | At Loss |
| 2023-06-06 | At Loss | 2023-04-04 | At Loss |
| 2023-06-05 | At Loss | 2023-04-03 | At Loss |
| 2023-06-02 | At Loss | 2023-03-31 | At Loss |
| 2023-06-01 | At Loss | 2023-03-30 | At Loss |
| 2023-05-31 | At Loss | 2023-03-29 | At Loss |
| 2023-05-30 | At Loss | 2023-03-28 | At Loss |
| 2023-05-29 | At Loss | 2023-03-27 | At Loss |
| 2023-05-26 | At Loss | 2023-03-24 | At Loss |
| 2023-05-25 | At Loss | 2023-03-23 | At Loss |
| 2023-05-24 | At Loss | 2023-03-22 | At Loss |
| 2023-05-23 | At Loss | 2023-03-21 | At Loss |
| 2023-05-22 | At Loss | 2023-03-20 | At Loss |
| 2023-05-19 | At Loss | 2023-03-17 | At Loss |
| 2023-05-18 | At Loss | 2023-03-16 | At Loss |
| 2023-05-17 | At Loss | 2023-03-15 | At Loss |
| 2023-05-16 | At Loss | 2023-03-14 | At Loss |
| 2023-05-15 | At Loss | 2023-03-13 | At Loss |
| 2023-05-12 | At Loss | 2023-03-10 | At Loss |
| 2023-05-11 | At Loss | 2023-03-09 | At Loss |
| 2023-05-10 | At Loss | 2023-03-08 | At Loss |
| 2023-05-09 | At Loss | 2023-03-07 | At Loss |
| 2023-05-08 | At Loss | 2023-03-06 | At Loss |
| 2023-05-05 | At Loss | 2023-03-03 | At Loss |
| 2023-05-04 | At Loss | 2023-03-02 | At Loss |
| 2023-05-03 | At Loss | 2023-03-01 | At Loss |
| 2023-05-02 | At Loss | 2023-02-28 | At Loss |
| 2023-05-01 | At Loss | 2023-02-27 | At Loss |
| 2023-04-28 | At Loss | 2023-02-24 | At Loss |
| 2023-04-27 | At Loss | 2023-02-23 | At Loss |
| 2023-04-26 | At Loss | 2023-02-22 | At Loss |
| 2023-04-25 | At Loss | 2023-02-21 | At Loss |
| 2023-04-24 | At Loss | 2023-02-20 | At Loss |
| 2023-04-21 | At Loss | 2023-02-17 | At Loss |
| 2023-04-20 | At Loss | 2023-02-16 | At Loss |
| 2023-04-19 | At Loss | 2023-02-15 | At Loss |
| 2023-04-18 | At Loss | 2023-02-14 | At Loss |
| 2023-04-17 | At Loss | 2023-02-13 | At Loss |
| 2023-04-14 | At Loss | 2023-02-10 | At Loss |
| 2023-04-13 | At Loss | 2023-02-09 | At Loss |
| 2023-04-12 | At Loss | 2023-02-08 | At Loss |
| 2023-04-11 | At Loss | 2023-02-07 | At Loss |
| 2023-04-10 | At Loss | 2023-02-06 | At Loss |
Vectus Biosystems Ltd (ASX:VBS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Vectus Biosystems Ltd
ISIN : AU000000VBS9
Compare
Compare
Traded in other countries / regions
VBS.Australia IPO Date
2016-02-23Description
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers